Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Join Us for Ruth’s 250th Daily Dip for Dave!
Can we get 250 people around the world dipping on the 15th of June? Ruth, the incredible wife of a neuroendocrine cancer patient, has been taking a daily sea swim for nearly a year to raise awareness and funds for Neuroendocrine Cancer UK. As Ruth shares, “My husband...
Neuroendocrine Cancer UK: PERT UPDATE 30th May 2024
As you may be aware, over the last few months, we at Neuroendocrine Cancer UK, have been working with charity partners to address the urgent need to resolve the persistent shortage of PERT (Pancreatic Enzyme Replacement Therapy) medications: Creon®, Nutrizym® 22 and...
SIRT Therapy for Neuroendocrine Tumours Webi-Natter Event – May 30th
- Neuroendocrine Cancer UK is thrilled to announce an upcoming Webi-Natter event focused on the recent news of NICE's approval of SIRT Therapy for neuroendocrine tumours. Scheduled for May 30th from 6:00pm to 7:30pm (GMT), this event will delve into the implications...